TERT-BUTYL 3-(HYDROXYIMINO)AZETIDINE-1-CARBOXYLATE, 95.0%, 5g

2-Amino-1-(4-(benzyloxy)phenyl)ethanone hydrochloride, 95%, 5g

Morpholin-2-ylacetic acid, 97.0%, 10g

[(1-acetyl-3-piperidinyl)methyl]amine hydrochloride, 95.0%, 5g

N-(2-Dimethylaminoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 250mg

tert-Butyl (3,6-dichloropyridazin-4-yl)carbamate, 95.0%, 250mg

Sal trisódica del ácido diacético de metilglicina (MGDA), mínimo 85 %, 500 g, envase de plástico.

3-ethyl-3-piperidinecarbonitrile hydrochloride, 95.0%, 5g

Depósito de muestras Visco, 650 ml, PTFE, FEP, 1 pieza

tert-Butyl (1R*,4R*)-4-(4-nitrobenzylamino)cyclohexylcarbamate, 1g

Pyridazine-4,5-dicarboxylic acid, 95.0%, 5g

tert-butyl N-[4-bromo-2-(trifluoromethyl)phenyl]carbamate, 98%, 25g

4-Amino-2,3,5,6-tetrafluorobenzoic Acid>97.0%(T)1g